NO20004215L - Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav - Google Patents

Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav

Info

Publication number
NO20004215L
NO20004215L NO20004215A NO20004215A NO20004215L NO 20004215 L NO20004215 L NO 20004215L NO 20004215 A NO20004215 A NO 20004215A NO 20004215 A NO20004215 A NO 20004215A NO 20004215 L NO20004215 L NO 20004215L
Authority
NO
Norway
Prior art keywords
angiotensin
type
pharmaceutical composition
receptor agonist
agonist
Prior art date
Application number
NO20004215A
Other languages
English (en)
Other versions
NO20004215D0 (no
Inventor
Lars Fondriks
Anders Pettersson
Anders Hallberg
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Publication of NO20004215D0 publication Critical patent/NO20004215D0/no
Publication of NO20004215L publication Critical patent/NO20004215L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20004215A 1998-02-24 2000-08-23 Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav NO20004215L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800550A SE9800550D0 (sv) 1998-02-24 1998-02-24 A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
PCT/SE1999/000262 WO1999043339A1 (en) 1998-02-24 1999-02-24 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof

Publications (2)

Publication Number Publication Date
NO20004215D0 NO20004215D0 (no) 2000-08-23
NO20004215L true NO20004215L (no) 2000-09-18

Family

ID=20410283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004215A NO20004215L (no) 1998-02-24 2000-08-23 Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav

Country Status (18)

Country Link
EP (1) EP1066048A1 (no)
JP (1) JP2002504516A (no)
KR (1) KR20010041211A (no)
CN (1) CN1291104A (no)
AU (1) AU755949B2 (no)
BR (1) BR9908188A (no)
CA (1) CA2319123A1 (no)
EE (1) EE200000481A (no)
HU (1) HUP0101411A3 (no)
ID (1) ID26639A (no)
IL (1) IL137990A0 (no)
IS (1) IS5594A (no)
MX (1) MXPA00008172A (no)
NO (1) NO20004215L (no)
NZ (1) NZ506188A (no)
SE (1) SE9800550D0 (no)
SK (1) SK11522000A3 (no)
WO (1) WO1999043339A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821953B1 (en) 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
AU1793101A (en) * 1999-12-16 2001-06-25 University Of Southern California Methods for treating and preventing damage to mucosal tissue
WO2002096883A1 (en) 2001-05-31 2002-12-05 Vicore Pharma Ab Tricyclic compounds useful as angiotensin ii agonists
KR101488812B1 (ko) 2005-04-12 2015-02-02 바이코어 파마 아베 신규한 비시클릭 안지오텐신 ⅱ 아고니스트
JP5202301B2 (ja) 2005-04-12 2013-06-05 ヴィコール・ファルマ・アーベー 新規な三環系アンジオテンシンｉｉアゴニスト
DE602006018122D1 (de) 2005-04-12 2010-12-23 Vicore Pharma Ab Neue tricyclische angiotensin-ii-agonisten
US20080317670A1 (en) * 2005-12-14 2008-12-25 Ambrx, Inc. Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
US8835471B2 (en) 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
WO2013158628A1 (en) * 2012-04-16 2013-10-24 New York University Modulation of angiotensin ii peceptors for the prevention and treatment of cerebral malaria
HK1244232A1 (zh) 2015-03-02 2018-08-03 维科尔药物公司 用於治疗肺纤维化的血管紧张素ii受体激动剂
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition
JP2022542437A (ja) 2019-08-02 2022-10-03 ランティオペプ ベスローテン ヴェンノーツハップ 癌の処置に用いるアンジオテンシン２型（ａｔ２）受容体アゴニスト
GB201913603D0 (en) 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
WO2021186185A1 (en) 2020-03-19 2021-09-23 Vicore Pharma Ab Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii
GB202004094D0 (en) 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202006081D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006079D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202013721D0 (en) 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds
GB202104038D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
GB202104033D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
WO2022200785A1 (en) 2021-03-23 2022-09-29 Vicore Pharma Ab Selective angiotensin ii receptor ligands
EP4367110A1 (en) 2021-07-09 2024-05-15 Vicore Pharma AB New selective angiotensin ii compounds
GB202115303D0 (en) 2021-10-25 2021-12-08 Vicore Pharma Ab New formulation
GB202201723D0 (en) 2022-02-10 2022-03-30 Vicore Pharma Ab New use
WO2023152503A1 (en) 2022-02-10 2023-08-17 Vicore Pharma Ab Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis
KR20250002355A (ko) 2022-04-06 2025-01-07 우한 휴먼웰 이노베이티브 드러그 리서치 앤드 디벨롭먼트 센터 리미티드 컴퍼니 Ａｔ２ｒ 작용제
WO2024133942A1 (en) 2022-12-22 2024-06-27 Vicore Pharma Ab A method of treating a patient diagnosed with an interstitial lung disease
JP2026502510A (ja) 2023-01-09 2026-01-23 ヴィコール ファルマ アーベー 選択的アンジオテンシンｉｉ化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444067A (en) * 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO1996014060A1 (en) * 1994-11-04 1996-05-17 Marklund Stefan L Use of receptor agonists to stimulate superoxide dismutase activity
SE9501881D0 (sv) * 1995-05-19 1995-05-19 Astra Ab New pharmacological use of AII-receptor antagonists
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
SE9502219D0 (sv) * 1995-06-19 1995-06-19 Astra Ab Novel medical use

Also Published As

Publication number Publication date
EE200000481A (et) 2002-02-15
CN1291104A (zh) 2001-04-11
ID26639A (id) 2001-01-25
AU2753799A (en) 1999-09-15
IL137990A0 (en) 2001-10-31
HUP0101411A3 (en) 2002-11-28
HUP0101411A2 (hu) 2002-03-28
SK11522000A3 (sk) 2001-04-09
MXPA00008172A (es) 2002-06-21
SE9800550D0 (sv) 1998-02-24
NZ506188A (en) 2003-04-29
JP2002504516A (ja) 2002-02-12
BR9908188A (pt) 2000-10-24
WO1999043339A1 (en) 1999-09-02
KR20010041211A (ko) 2001-05-15
EP1066048A1 (en) 2001-01-10
IS5594A (is) 2000-08-21
AU755949B2 (en) 2003-01-02
NO20004215D0 (no) 2000-08-23
CA2319123A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
NO20004215L (no) Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav
NO306398B1 (no) Substituerte N-(indol-2-karbonyl) glycinamider, anvendelse derav, mellomprodukt og farmasöytisk preparat
DK1019077T4 (da) Hidtil ukendte exendinagonistforbindelser
DZ2788A1 (fr) Agonistes et antagonistes selectifs à IL-2.
PT1177178E (pt) Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao
NO305435B1 (no) Ïstrogen-agonist/antagonister, farmas°ytisk preparat inneholdende disse og mellomprodukt derav
NO20043803L (no) Substituerte amider som er aktive i cannabinoid 1-reseptoren
NO20001612D0 (no) Oralt preparat
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
NO994906D0 (no) GnRH antagonister som er modifisert i stillinger 5 og 6
NO20001160D0 (no) Nytt skumdannende farmasøytisk preparat
IT1312366B1 (it) Resina copolimerica, sua preparazione e photoresist che la utilizza.
DK0733626T3 (da) N-(Benzofurazanyl)-arylsulfonamider og analoger deraf, der kan anvendes som endothelin-receptor-antagonister
NO306257B1 (no) 11-(substituert fenyl)-östra-4,9-dien-derivater, farmasöytisk preparat og anvendelse derav
NO20005399D0 (no) Farmasøytisk preparat
DK199900176U3 (da) Paroxetinsalte, farmaceutisk præparat indeholdende disse og anvendelser deraf
EP1112252A4 (en) KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF
NO996115D0 (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
NO20004316D0 (no) Meta azasykliske aminobenzosyreforbindelser og derivater derav som er integrinatantagonister
NO20004668D0 (no) 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister
DK1237559T3 (da) Farmaceutiske kombinationer som omfatter en P2T-receptor-antagonist og melagatran
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
NO20004277L (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
MA26890A1 (fr) Metabolites agonistes/ antagonistes d'oestrogenes
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application